Table 1 Patient characteristics at the first time of SBRT (n = 14)
Characteristics | |
|---|---|
Age, median (range) | 55.5 (40–68) |
Male, no. (%) | 12 (85.7) |
Cause of cirrhosis, no. (%) | |
HBV | 11 (78.6) |
HCV | 2 (14.3) |
Alcoholic | 1 (7.1) |
ECOG performance status, no. (%) | |
0 | 9 (64.3) |
1 | 4 (28.6) |
2 | 1 (7.1) |
Child–Pugh class, no. (%) | |
A | 11 (78.6) |
B | 2 (14.3) |
C | 1 (7.1) |
Previous treatment, no. (%) | |
TACE | 7 (50.0) |
RFA + TACE | 1 (7.1) |
TACE + Thaldo | 2 (14.3) |
Segmentectomy + TACE | 2 (14.3) |
Segmentectomy + TACE + RFA | 1 (7.1) |
None | 1 (7.1) |
Max. tumor diameter, median (range) | 4.45 (0.9–10.5) |
Number of tumors, no. (%) | |
Solitary | 4 (28.6) |
Multiple | 10 (71.4) |
Portal venous tumor thrombosis, no. (%) | 4 (28.6) |
AFP, median (range), IU/mL | 59.5 (3.0–1286.0) |
BCLC stage at SBRT, no. (%) | |
A | 3 (21.4) |
B | 6 (42.9) |
C | 4 (28.6) |
D | 1 (7.1) |
Within Milan criteria before SBRT, no. (%) | 4 (28.6) |